The ‘National Institutes for Quantum and Radiological Science and Technology (QST)’ has been announced as a partner organisation of the CNBP at an official launch event held in Japan, October 15th, 2018.
The QST, a merger of the National Institute of Radiological Sciences (NIRS) with operations that were previously undertaken by the Japan Atomic Energy Agency (JAEA), undertakes research and development into quantum science and technology, the effect of radiation on humans, radiation emergency medicine, and the medical use of radiation.
“The QST / CNBP partner launch was a huge success,” said CNBP Deputy Director A/Prof Brant Gibson, RMIT University.
“Our partner launch activities occurred over two site locations of the QST – Takasaki and Chiba, Japan.”
“At the Takasaki ‘materials’ site I presented the CNBP partner plaque to Hisayoshi Itoh (pictured top left), Director General of the Takasaki site (Takasaki Advanced Radiation Research Institute).”
“Our delegation then moved to the Chiba ‘medical’ site of QST (National Institute of Radiological Sciences). There they have a medical high energy carbon irradiation facility – of which there are only two existent globally – the other is in Heidelberg in Germany. We had the opportunity to meet with Yoshiya Shimada, Executive Director of the entire QST at the Chiba site where I presented the CNBP plaque a second time,” he said.
The CNBP / QST partnership launch coincided with the launch of a 3 year International Research Initiative (entitled Quantum biosensors in wide bandgap semiconductors) between QST and researchers from RMIT, CNBP, The University of Melbourne, CQC2T and the Fraunhofer IAF.
“This initiative will focus on fostering strategic collaboration between Japan, Australia and Germany through short to long term visits from researchers focused in the area of quantum biology,” said A/Prof Gibson.